Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2

Documenti analoghi

• Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect
  di: Kurebayashi, J, et al.
  Pubblicazione: (1999)
• Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6
  di: Kurebayashi, J, et al.
  Pubblicazione: (1999)
• Expression of Vascular Endothelial Growth Factor (VEGF) Family Members in Breast Cancer
  di: Kurebayashi, Junichi, et al.
  Pubblicazione: (1999)
• Additive antitumour effect of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) and the antioestrogen fulvestrant (Faslodex, ICI 182,780) in breast cancer cells
  di: Okubo, S, et al.
  Pubblicazione: (2004)
• A new human breast cancer cell line, KPL-1 secretes tumour-associated antigens and grows rapidly in female athymic nude mice.
  di: Kurebayashi, J., et al.
  Pubblicazione: (1995)